Exact Mass: 271.1718

Exact Mass Matches: 271.1718

Found 83 metabolites which its exact mass value is equals to given mass value 271.1718, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Prolyl-Arginine

5-Carbamimidamido-2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}pentanoate

C11H21N5O3 (271.1644)


Prolyl-Arginine is a dipeptide composed of proline and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Arginylproline

(2S)-1-[(2S)-2-Amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C11H21N5O3 (271.1644)


Arginylproline is a dipeptide composed of arginine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Hept-3-enoylcarnitine

3-(Hept-3-enoyloxy)-4-(trimethylazaniumyl)butanoic acid

C14H25NO4 (271.1783)


Hept-3-enoylcarnitine is an acylcarnitine. More specifically, it is an hept-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hept-3-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Hept-3-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Hept-4-enoylcarnitine

3-(hept-4-enoyloxy)-4-(trimethylazaniumyl)butanoate

C14H25NO4 (271.1783)


Hept-4-enoylcarnitine is an acylcarnitine. More specifically, it is an hept-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hept-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Hept-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Hept-5-enoylcarnitine

3-(hept-5-enoyloxy)-4-(trimethylazaniumyl)butanoate

C14H25NO4 (271.1783)


Hept-5-enoylcarnitine is an acylcarnitine. More specifically, it is an hept-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hept-5-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Hept-5-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Hept-2-enoylcarnitine

3-(hept-2-enoyloxy)-4-(trimethylazaniumyl)butanoate

C14H25NO4 (271.1783)


(2E)-hept-2-enoylcarnitine is an acylcarnitine. More specifically, it is an (2E)-hept-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-hept-2-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-hept-2-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

O-Desmethyl Pyrilamine

4-({[2-(dimethylamino)ethyl](pyridin-2-yl)amino}methyl)phenol

C16H21N3O (271.1685)


   

Pyrido[2,3-d]pyrimidin-2(1H)-one, 4-cyclohexyl-1-ethyl-7-methyl-

Pyrido[2,3-d]pyrimidin-2(1H)-one, 4-cyclohexyl-1-ethyl-7-methyl-

C16H21N3O (271.1685)


   

O-Desmethyl Pyrilamine

O-Desmethyl Pyrilamine

C16H21N3O (271.1685)


   

MCULE-1419399906

MCULE-1419399906

C14H25NO4 (271.1783)


   

2-((2-Methylaminoethyl)(p-methoxybenzyl)amino)pyridine

2-((2-Methylaminoethyl)(p-methoxybenzyl)amino)pyridine

C16H21N3O (271.1685)


   

N-(3-Hydroxydecanoyl)-DL-homoserine lactone

N-(3-Hydroxydecanoyl)-DL-homoserine lactone

C14H25NO4 (271.1783)


   

N-[3-(2,3,4,9-Tetrahydro-1H-b-carbolin-1-yl)-propyl]-guanidine

N-[3-(2,3,4,9-Tetrahydro-1H-b-carbolin-1-yl)-propyl]-guanidine

C15H21N5 (271.1797)


   
   
   

4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid

NCGC00380621-01!4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid

C14H25NO4 (271.1783)


   

PYR_272.1759_11.0

2-((2-Methylaminoethyl)(p-methoxybenzyl)amino)pyridine

C16H21N3O (271.1685)


CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); INTERNAL_ID 1702

   

PYR_272.1759_8.8

PYR_272.1759_8.8

C16H21N3O (271.1685)


CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); INTERNAL_ID 1703

   

4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid

4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid

C14H25NO4 (271.1783)


   

3-hydroxy-C10-homoserine lactone

3-hydroxy-C10-homoserine lactone

C14H25NO4 (271.1783)


CONFIDENCE standard compound; INTERNAL_ID 216

   

4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid [IIN-based on: CCMSLIB00000847798]

NCGC00380621-01!4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid [IIN-based on: CCMSLIB00000847798]

C14H25NO4 (271.1783)


   

4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid [IIN-based: Match]

NCGC00380621-01!4-oxo-4-(3-oxodecan-2-ylamino)butanoic acid [IIN-based: Match]

C14H25NO4 (271.1783)


   
   
   

Arg-pro

5-carbamimidamido-2-(pyrrolidin-2-ylformamido)pentanoic acid

C11H21N5O3 (271.1644)


   

Pro-arg

1-(2-amino-5-carbamimidamidopentanoyl)pyrrolidine-2-carboxylic acid

C11H21N5O3 (271.1644)


A dipeptide formed from L-proline and L-arginine residues.

   

3OH-C10-HSL

N-(3-hydroxy-decanoyl)-homoserine lactone

C14H25NO4 (271.1783)


   

N-Boc-4-ethyl piperidinecarboxylate

N-Boc-4-ethyl piperidinecarboxylate

C14H25NO4 (271.1783)


   

1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate

1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate

C14H25NO4 (271.1783)


   

2-N-BOC-AMINOMETHYL-2-CYCLOHEXYLACETICACID

2-N-BOC-AMINOMETHYL-2-CYCLOHEXYLACETICACID

C14H25NO4 (271.1783)


   

2-Methyl-2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionitrile

2-Methyl-2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionitrile

C16H22BNO2 (271.1744)


   

Methyl N-Boc-4-piperidinepropionate

Methyl N-Boc-4-piperidinepropionate

C14H25NO4 (271.1783)


   

N-(2-diethylaminoethyl)quinoline-2-carboxamide

N-(2-diethylaminoethyl)quinoline-2-carboxamide

C16H21N3O (271.1685)


   

(2R,3R)-3-(3-Methoxyphenyl)-N,N,2-trimethylpentan-1-amine hydrochloride

(2R,3R)-3-(3-Methoxyphenyl)-N,N,2-trimethylpentan-1-amine hydrochloride

C15H26ClNO (271.1703)


   

β-Dihydroequilin-d3

β-Dihydroequilin-d3

C18H17D3O2 (271.1652)


   

Ethyl N-Boc-4-methylpiperidine-4-carboxylate

Ethyl N-Boc-4-methylpiperidine-4-carboxylate

C14H25NO4 (271.1783)


   

2-(2-METHOXYCARBONYL-ETHYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

2-(2-METHOXYCARBONYL-ETHYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H25NO4 (271.1783)


   

1-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENYL]-2,5-DIHYDRO-1H-PYRROLE

1-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENYL]-2,5-DIHYDRO-1H-PYRROLE

C16H22BNO2 (271.1744)


   

2,3-DICHLOROBENZOICACID

2,3-DICHLOROBENZOICACID

C14H25NO4 (271.1783)


   
   

3-Methyl 1-(2-methyl-2-propanyl) 3-ethyl-1,3-piperidinedicarboxyl ate

3-Methyl 1-(2-methyl-2-propanyl) 3-ethyl-1,3-piperidinedicarboxyl ate

C14H25NO4 (271.1783)


   

2-Methyl-2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionitrile

2-Methyl-2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionitrile

C16H22BNO2 (271.1744)


   

(2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethyl-pentanamine hydrochloride

(2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethyl-pentanamine hydrochloride

C15H26ClNO (271.1703)


   

1-BENZYL-3-PHENYL-2-THIOUREA

1-BENZYL-3-PHENYL-2-THIOUREA

C18H22FN (271.1736)


   

1-Boc-4-isopropyl-4-piperidinecarboxylic Acid

1-Boc-4-isopropyl-4-piperidinecarboxylic Acid

C14H25NO4 (271.1783)


   

BOC-1-AMINO-1-CYCLOOCTANECARBOXYLIC ACID

BOC-1-AMINO-1-CYCLOOCTANECARBOXYLIC ACID

C14H25NO4 (271.1783)


   

(R)-2-tert-Butoxycarbonylamino-3-cyclohexylpropionic acid

(R)-2-tert-Butoxycarbonylamino-3-cyclohexylpropionic acid

C14H25NO4 (271.1783)


   

TERT-BUTYL 3-(2-ETHOXY-2-OXOETHYL)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 3-(2-ETHOXY-2-OXOETHYL)PIPERIDINE-1-CARBOXYLATE

C14H25NO4 (271.1783)


   

Tert-Butyl 3-(Hydroxymethyl)-2-Oxa-8-Azaspiro[4.5]Decane-8-Carboxylate

Tert-Butyl 3-(Hydroxymethyl)-2-Oxa-8-Azaspiro[4.5]Decane-8-Carboxylate

C14H25NO4 (271.1783)


   

(2S,4S)-N-BOC-4-HYDROXY-3,3-DIMETHYLPYRROLIDINE-2-CARBOXYLICACID

(2S,4S)-N-BOC-4-HYDROXY-3,3-DIMETHYLPYRROLIDINE-2-CARBOXYLICACID

C14H25NO4 (271.1783)


   

N-Boc-4-Piperidin-4-yl-butyric acid

N-Boc-4-Piperidin-4-yl-butyric acid

C14H25NO4 (271.1783)


   

ethyl 3-[2-(2-ethoxy-2-oxoethyl)piperidin-1-yl]propanoate

ethyl 3-[2-(2-ethoxy-2-oxoethyl)piperidin-1-yl]propanoate

C14H25NO4 (271.1783)


   

4-N-BOC-CYCLOHEXYACETIC ACID METHYL ESTER

4-N-BOC-CYCLOHEXYACETIC ACID METHYL ESTER

C14H25NO4 (271.1783)


   

1-TERT-BUTYL 4-METHYL 4-ETHYLPIPERIDINE-1,4-DICARBOXYLATE

1-TERT-BUTYL 4-METHYL 4-ETHYLPIPERIDINE-1,4-DICARBOXYLATE

C14H25NO4 (271.1783)


   

3-(Boc-amino)-3-cyclohexylpropionic Acid

3-(Boc-amino)-3-cyclohexylpropionic Acid

C14H25NO4 (271.1783)


   

1-cyclohexyl-3-(2-morpholinoethyl)thiourea

1-cyclohexyl-3-(2-morpholinoethyl)thiourea

C13H25N3OS (271.1718)


   

(2S,4S)-6-FLUORO-2,5-DIOXO-2,3-DIHYDROSPIRO[CHROMENE-4,4-IMIDAZOLIDINE]-2-CARBOXAMIDE

(2S,4S)-6-FLUORO-2,5-DIOXO-2,3-DIHYDROSPIRO[CHROMENE-4,4-IMIDAZOLIDINE]-2-CARBOXAMIDE

C14H25NO4 (271.1783)


   

[(1S)-3-Methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamic acid 1,1-dimethylethyl ester

[(1S)-3-Methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamic acid 1,1-dimethylethyl ester

C14H25NO4 (271.1783)


   

tert-butyl 2-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate

tert-butyl 2-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate

C14H25NO4 (271.1783)


   

2-BROMO-6-SEC-BUTOXYPYRIDINE

2-BROMO-6-SEC-BUTOXYPYRIDINE

C14H25NO4 (271.1783)


   
   

1-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester

1-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester

C14H25NO4 (271.1783)


   

3-Isopropyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-3-piperidineca rboxylic acid

3-Isopropyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-3-piperidineca rboxylic acid

C14H25NO4 (271.1783)


   

(S)-4,4-DIMETHYL-PYRROLIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER 2-ETHYL ESTER

(S)-4,4-DIMETHYL-PYRROLIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER 2-ETHYL ESTER

C14H25NO4 (271.1783)


   

Pyrido[2,3-d]pyrimidin-2(1H)-one, 4-cyclohexyl-1-ethyl-7-methyl-

Pyrido[2,3-d]pyrimidin-2(1H)-one, 4-cyclohexyl-1-ethyl-7-methyl-

C16H21N3O (271.1685)


   

Lysine-2-naphthylamide

Lysine-2-naphthylamide

C16H21N3O (271.1685)


   

3-hydroxy-N-(2-oxooxolan-3-yl)decanamide

3-hydroxy-N-(2-oxooxolan-3-yl)decanamide

C14H25NO4 (271.1783)


   

3-Hydroxy-N-[(3S)-2-oxooxolan-3-yl]decanamide

3-Hydroxy-N-[(3S)-2-oxooxolan-3-yl]decanamide

C14H25NO4 (271.1783)


   

Hept-3-enoylcarnitine

Hept-3-enoylcarnitine

C14H25NO4 (271.1783)


   

Hept-4-enoylcarnitine

Hept-4-enoylcarnitine

C14H25NO4 (271.1783)


   

Hept-5-enoylcarnitine

Hept-5-enoylcarnitine

C14H25NO4 (271.1783)


   

(2E)-Hept-2-enoylcarnitine

(2E)-Hept-2-enoylcarnitine

C14H25NO4 (271.1783)


   

5-(4-Propylcyclohexyl)-3-(3-pyridinyl)-1,2,4-oxadiazole

5-(4-Propylcyclohexyl)-3-(3-pyridinyl)-1,2,4-oxadiazole

C16H21N3O (271.1685)


   

4-Oxo-4-[(3-oxo-2-decanyl)amino]butanoic acid

4-Oxo-4-[(3-oxo-2-decanyl)amino]butanoic acid

C14H25NO4 (271.1783)


   

2-Benzyl-5-[(3S)-1-isopropyl-3-pyrrolidinyl]-1,3,4-oxadiazole

2-Benzyl-5-[(3S)-1-isopropyl-3-pyrrolidinyl]-1,3,4-oxadiazole

C16H21N3O (271.1685)


   
   
   

mGluR3 modulator-1

mGluR3 modulator-1

C16H21N3O (271.1685)


mGluR3 modulator-1 (compound 3) is a mGluR3 modulator, with an EC50 of 1-10 μM in HEK293T-mGluR-Gqi5 Calcium Mobilization Assay[1].

   

hexahydro-1h-pyrrolizin-1-ylmethyl 2,3-dihydroxy-3-methylpentanoate

hexahydro-1h-pyrrolizin-1-ylmethyl 2,3-dihydroxy-3-methylpentanoate

C14H25NO4 (271.1783)


   

(3s)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]decanimidic acid

(3s)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]decanimidic acid

C14H25NO4 (271.1783)


   

(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3r)-2,3-dihydroxy-3-methylpentanoate

(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3r)-2,3-dihydroxy-3-methylpentanoate

C14H25NO4 (271.1783)


   

n-{3-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]propyl}guanidine

n-{3-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]propyl}guanidine

C15H21N5 (271.1797)


   

3-hydroxy-n-(2-oxooxolan-3-yl)decanimidic acid

3-hydroxy-n-(2-oxooxolan-3-yl)decanimidic acid

C14H25NO4 (271.1783)